However, bioinformatic and computational analysis suggest that this miRNA may be involved in the pathogenesis and complications of T2D through its predicted targets, the mitogen activated protein kinase MAP3K1 and HMGA1, whose transcripts and 3′UTR regions have putative binding sites for hsa-miR-1225-3p. This evidence concerns the gene MAP3K1 and type 2 diabetes mellitus.